NeuroFrontiers
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
1-15 of 381
ADHD Medication Dose-Effect Patterns Vary by Age and Drug Class
NeuroFrontiersADHD Medication Dose-Effect Patterns Vary by Age and Drug Class
ADHD Is Linked to a Broad Burden of GI Symptoms
NeuroFrontiersADHD Is Linked to a Broad Burden of GI Symptoms
Diagnosing Adult ADHD in the Social Media Era
NeuroFrontiersDiagnosing Adult ADHD in the Social Media Era
Jill RachBeisel, MD
Untangling ADHD from Depression, Anxiety, and Substance Use Disorder
NeuroFrontiersUntangling ADHD from Depression, Anxiety, and Substance Use Disorder
Jill RachBeisel, MD
James Swanson, PhD
James Swanson, PhD
- advertisement
Can We Delay Alzheimer's Symptoms Before They Begin? Inside the PrevenTRON Trial
NeuroFrontiersCan We Delay Alzheimer's Symptoms Before They Begin? Inside the PrevenTRON Trial
Geoff Kerchner
Rethinking Migraine Prevention: Where CGRP-Targeting Therapies Fit
NeuroFrontiersRethinking Migraine Prevention: Where CGRP-Targeting Therapies Fit
Alexandria May, PharmD, BCPS
Nina Riggins, MD
Subcutaneous Lecanemab for Early Alzheimer Disease: Evidence, Safety, and Patient Selection
NeuroFrontiersSubcutaneous Lecanemab for Early Alzheimer Disease: Evidence, Safety, and Patient Selection
Michael Irizarry, MD, MPH
Understanding CIDP: Disease Heterogeneity and Diagnostic Challenges
Medical Industry FeatureUnderstanding CIDP: Disease Heterogeneity and Diagnostic Challenges
Jennifer Caudle, DO, FACOFP
Allison Crowell, MD
Next-Generation CNS Drug Delivery: Brainshuttle Technology and Clinical Implications in Alzheimer Disease
NeuroFrontiersNext-Generation CNS Drug Delivery: Brainshuttle Technology and Clinical Implications in Alzheimer Disease
Luka Kulic, MD
Roberto Olivardia, PhD
- advertisement
James Swanson, PhD
Supporting Students with ADHD and Learning Differences
NeuroFrontiersSupporting Students with ADHD and Learning Differences
Roberto Olivardia, PhD
Long-Term ADHD Treatment: Examining Stimulant Tolerance
NeuroFrontiersLong-Term ADHD Treatment: Examining Stimulant Tolerance
James Swanson, PhD
